PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.340
-0.080 (-5.63%)
At close: Feb 21, 2025, 4:00 PM
1.440
+0.100 (7.46%)
After-hours: Feb 21, 2025, 6:04 PM EST
PDS Biotechnology Employees
PDS Biotechnology had 25 employees as of December 31, 2023. The number of employees decreased by 1 or -3.85% compared to the previous year.
Employees
25
Change (1Y)
-1
Growth (1Y)
-3.85%
Revenue / Employee
n/a
Profits / Employee
-$1,622,250
Market Cap
50.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | 15 | 0 | - |
| Dec 31, 2019 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
PDSB News
- 3 days ago - PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025 - GlobeNewsWire
- 2 months ago - PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET - GlobeNewsWire
- 3 months ago - PDS Biotechnology Corporation (PDSB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time - GlobeNewsWire
- 5 months ago - PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation - GlobeNewsWire
- 5 months ago - PDS Biotechnology: Continuing The Holding Pattern - Seeking Alpha
- 5 months ago - PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 - GlobeNewsWire